Rosenson RS, Goonewardena SN. The residual risk Odyssey: from LDL to Lp(a). J Am Coll Cardiol. 2021;78(5):434–6. https://doi.org/10.1016/j.jacc.2021.04.103

Reyes‐Soffer G, Ginsberg HN, Berglund L, Duell PB, Heffron SP, Kamstrup PR, et al. Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American Heart Association. Arterioscler Thromb Vasc Biol. 2022;42(1):e48–e60. https://doi.org/10.1161/ATV.0000000000000147

Stefanutti C, Thompson GR. Lipoprotein apheresis in the management of familial hypercholesterolaemia: historical perspective and recent advances. Curr Atherosclerosis Rep. 2015;17(1):465. https://doi.org/10.1007/s11883-014-0465-6

Li JJ, Ma CS, Zhao D, Yan XW. Lipoprotein(a) and cardiovascular disease in Chinese population: a Beijing Heart Society Expert Scientific Statement. JACC Asia. 2022;2(6):653–65. https://doi.org/10.1016/j.jacasi.2022.08.015

Gaw A, Boerwinkle E, Cohen JC, Hobbs HH. Comparative analysis of the apo(a) gene, apo(a) glycoprotein, and plasma concentrations of Lp(a) in three ethnic groups. Evidence for no common "null" allele at the apo(a) locus. J Clin Invest. 1994;93(6):2526–34. https://doi.org/10.1172/JCI117263

Lanktree MB, Anand SS, Yusuf S, Hegele RA; SHARE Investigators. Comprehensive analysis of genomic variation in the LPA locus and its relationship to plasma lipoprotein(a) in South Asians, Chinese, and European Caucasians. Circ Cardiovasc Genet. 2010;3(1):39–46. https://doi.org/10.1161/CIRCGENETICS.109.907642

Liu Y, Ma H, Zhu Q, Zhang B, Yan H, Li H, et al. A genome‐wide association study on lipoprotein (a) levels and coronary artery disease severity in a Chinese population. J Lipid Res. 2019;60(8):1440–8. https://doi.org/10.1194/jlr.P091009